PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2017

Acute administration of catalase targeted to ICAM-1 attenuates neuropathology in experimental traumatic brain injury.

Mouse / TBI

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 28630485 ↗2017Reported benefit

Acute administration of catalase targeted to ICAM-1 attenuates neuropathology in experimental traumatic brain injury.

MouseTBIControlled cortical impactC57BL/6J; CX3CR1-GFP (B6.129P-Cx3cr1tm1Litt/J) for two-photon microglial imagingMalen = n = 4 per condition for hydrogen peroxide assay; n = 3 mice…Intravenous, by retro-orbital injection100 ug anti-ICAM-1/catalase conjugate per mouse; comparator…30 min after controlled cortical impact

Model: Moderate controlled cortical impact traumatic brain injury: 4 mm craniectomy over right somatosensory cortex, impact at 3.5 m/s to 1 mm depth with a 2 mm piston and 0.5 s dwell time

Targeted anti-ICAM-1/catalase given 30 min post-impact normalised cortical hydrogen peroxide, cut 3-nitrotyrosine, preserved blood-brain barrier integrity and tight junction proteins, and reduced neuronal loss, astrogliosis and microglial activation. Non-targeted catalase or anti-ICAM-1 antibody al…

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.